Xi Ding
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Lung Cancer Treatments and Mutations
- Ferroptosis and cancer prognosis
Papers in
-
- Cancer therapeutics and mechanisms 3
- PI3K/AKT/mTOR signaling in cancer 3
- Cell death mechanisms and regulation 2
- Cancer-related gene regulation 2
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Bo Su (15 shared papers)Di Liu (10 shared papers)Wen Xu (3 shared papers)Wen Xu (8 shared papers)Yifeng Sun (4 shared papers)Wen Gao (3 shared papers)Jingyun Shi (2 shared papers)Zengli Zhang (1 shared paper)
- Journals
- Clinical & Translational Oncology (3 papers)Journal of Cancer (2 papers)Food and Agricultural Immunology (1 paper)Applied Physics Letters (1 paper)Analytical Letters (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xi Ding
31 papers receiving 382 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 79
- Pulmonary and Respiratory Medicine 90
- Oncology 75
- Molecular Biology 175
- Biomaterials 23
Countries citing papers authored by Xi Ding
This map shows the geographic impact of Xi Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Ding more than expected).
Fields of papers citing papers by Xi Ding
This network shows the impact of papers produced by Xi Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Ding. The network helps show where Xi Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Xi Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 48 | |
| 2 | 2018 | 42 | |
| 3 | 2020 | 30 | |
| 4 | 2017 | 21 | |
| 5 | 2018 | 18 | |
| 6 | EFNB2 acts as the target of miR-557 to facilitate cell proliferation, migration and invasion in pancreatic ductal adenocarcinoma by bioinformatics analysis and verification. | 2018 | 18 |
| 7 | 2017 | 17 | |
| 8 | 2017 | 16 | |
| 9 | 2016 | 15 | |
| 10 | 2017 | 15 | |
| 11 | 2019 | 14 | |
| 12 | 2016 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 2020 | 11 | |
| 15 | 2016 | 11 | |
| 16 | 2024 | 10 | |
| 17 | 2022 | 10 | |
| 18 | 2024 | 9 | |
| 19 | 2018 | 9 | |
| 20 | 2016 | 8 |
About Xi Ding
Xi Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Biomedical Engineering, having authored 32 papers that have together received 390 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Cancer therapeutics and mechanisms (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Phytochemicals and Antioxidant Activities (2 papers), Metal and Thin Film Mechanics (2 papers), Cell death mechanisms and regulation (2 papers), Cancer-related Molecular Pathways (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (79 citations), Pulmonary and Respiratory Medicine (90 citations), Oncology (75 citations), Molecular Biology (175 citations) and Biomaterials (23 citations). Xi Ding has collaborated with scholars based in China and United States. Frequent co-authors include Bo Su, Di Liu, Wen Xu, Wen Xu, Yifeng Sun, Wen Gao, Jingyun Shi, Zengli Zhang, Tao Jiang and Xuefei Li. Their work appears in journals such as Clinical & Translational Oncology, Journal of Cancer, Food and Agricultural Immunology, Applied Physics Letters and Analytical Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.